Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Martinez

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Plos Biology|July 10, 2015
Biofilm Formation As a Response to Ecological CompetitionNuno M Oliveira, Nuno M Oliveria, Esteban Martinez-Garcia, et al.
BMC Infectious Diseases|August 8, 2012
Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistancePaula Freitas, Davide Carvalho, Ana Cristina Santos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) EraGiovanni Guaraldi, Jovana Milic, Esteban Martinez, et al.
Antiviral Therapy|March 27, 2009
Body image is a major determinant of sexual dysfunction in stable HIV-infected womenKety Luzi, Giovanni Guaraldi, Rita Murri, et al.
Journal of Lipid Research|September 15, 2018
Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposedOlivia Tort, Tuixent Escribà, Lander Egaña-Gorroño, et al.
HIV Medicine|July 5, 2026
Mpox clinical outcomes among people living with HIV and PrEP users: Findings from the MASH-1 multicentre cohort studyNicolo Girometti, Andrew Hill, Bryony Simmons, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2018
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trialJose L Blanco, Jhon Rojas, Roger Paredes, et al.
AIDS (London, England)|July 10, 2023
An opinion piece on how we move towards common European standards of care for people with HIVJürgen Rockstroh, Kamilla G Laut, Stine F Jakobsen, et al.
The Journal of Antimicrobial Chemotherapy|July 29, 2025
Hypertension and blood pressure changes with dolutegravir or comparator antiretroviral therapy in randomized trials through 96 weeksParul Patel, Ana Milinkovic, Richard Grove, et al.
Antiviral Therapy|December 19, 2002
Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving post-exposure prophylaxisFelipe Garcia, Montserrat Plana, Gabriel Mestre, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Plos Biology|July 10, 2015
Biofilm Formation As a Response to Ecological CompetitionNuno M Oliveira, Nuno M Oliveria, Esteban Martinez-Garcia, et al.
BMC Infectious Diseases|August 8, 2012
Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistancePaula Freitas, Davide Carvalho, Ana Cristina Santos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) EraGiovanni Guaraldi, Jovana Milic, Esteban Martinez, et al.
Antiviral Therapy|March 27, 2009
Body image is a major determinant of sexual dysfunction in stable HIV-infected womenKety Luzi, Giovanni Guaraldi, Rita Murri, et al.
Journal of Lipid Research|September 15, 2018
Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposedOlivia Tort, Tuixent Escribà, Lander Egaña-Gorroño, et al.
HIV Medicine|July 5, 2026
Mpox clinical outcomes among people living with HIV and PrEP users: Findings from the MASH-1 multicentre cohort studyNicolo Girometti, Andrew Hill, Bryony Simmons, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2018
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trialJose L Blanco, Jhon Rojas, Roger Paredes, et al.
AIDS (London, England)|July 10, 2023
An opinion piece on how we move towards common European standards of care for people with HIVJürgen Rockstroh, Kamilla G Laut, Stine F Jakobsen, et al.
The Journal of Antimicrobial Chemotherapy|July 29, 2025
Hypertension and blood pressure changes with dolutegravir or comparator antiretroviral therapy in randomized trials through 96 weeksParul Patel, Ana Milinkovic, Richard Grove, et al.
Antiviral Therapy|December 19, 2002
Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving post-exposure prophylaxisFelipe Garcia, Montserrat Plana, Gabriel Mestre, et al.
Pageof 17